SCHEMBL4498933

SCHEMBL4498933

FC1CCN(Cc2ncc[nH]2)C1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.64
ALDH1A1 P00352 2/20 0.45
KAT2B Q92831 1/20 0.43
KDM4E B2RXH2 1/20 0.42
LMNA P02545 1/20 0.42
PARP1 P09874 1/20 0.39
HRH3 Q9Y5N1 3/20 0.38
OPRM1 P35372 1/20 0.38
HTR4 Q13639 1/20 0.37
POLB P06746 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
F2RL1 P55085 2/20 0.36
HTR2B P41595 2/20 0.36
JAK2 O60674 3/20 0.36
JAK1 P23458 3/20 0.36
TYK2 P29597 3/20 0.36
JAK3 P52333 2/20 0.36
CDC7 O00311 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14197731 0.83 ALOX15 (0.62) ALOX15ALDH1A1KAT2BKDM4ELMNA
SCHEMBL2675650 0.82 ALOX15 (0.71) ALOX15ALDH1A1KAT2BKDM4ELMNA
SCHEMBL14375217 0.79 ALOX15 (0.71) ALOX15ALDH1A1KAT2BKDM4ELMNA
SCHEMBL15329166 0.79 ALOX15 (1.00) ALOX15ALDH1A1KAT2BKDM4ELMNA
SCHEMBL1202129 0.77 ALOX15 (0.58) ALOX15ALDH1A1KAT2BKDM4ELMNA
SCHEMBL15084311 0.77 ALOX15 (0.58) ALOX15ALDH1A1KAT2BKDM4ELMNA
SCHEMBL1202128 0.77 ALOX15 (0.58) ALOX15ALDH1A1KAT2BKDM4ELMNA
SCHEMBL4649153 0.76 ALOX15 (0.67) ALOX15ALDH1A1KAT2BKDM4ELMNA
SCHEMBL13512171 0.76 ALOX15 (0.67) ALOX15ALDH1A1KAT2BKDM4ELMNA
SCHEMBL1953418 0.75 ALOX15 (0.85) ALOX15ALDH1A1KAT2BKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7482374-B2 Pyrrolidine-2-ones as Factor Xa inhibitors GLAXO GROUP LIMITED (GB) 2009-01-27 US disclosed
US-7482374-B2 Pyrrolidine-2-ones as Factor Xa inhibitors GLAXO GROUP LIMITED (GB) 2009-01-27 US disclosed
US-7482374-B2 Pyrrolidine-2-ones as Factor Xa inhibitors GLAXO GROUP LIMITED (GB) 2009-01-27 US disclosed
US-20060167079-A1 Pyrrolidine -2-ones as factor xa inhibitors GLAXO GROUP LIMITED (GB) 2006-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060167079-A1 Pyrrolidine -2-ones as factor xa inhibitors TFPI, F2, F11 ALOX15 1843/4885ALDH1A1 1285/4885KAT2B 1623/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.